Core Scientific (CORZR) Capital Expenditures (2021 - 2026)

Core Scientific's Capital Expenditures history runs 6 years deep, the most recent figure standing at $389.2 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 363.47% year-over-year to $389.2 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 478.23% YoY), while the FY2025 annual figure was $729.0 million, up 667.68% from the prior year.
• Capital Expenditures came in at $389.2 million for Q1 2026 at Core Scientific, up from $279.2 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $389.2 million in Q1 2026 to a low of -$62.3 million in Q4 2022.
• A 5-year average of $83.0 million and a median of $22.5 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures plunged 99.89% in 2023 and surged 247408.16% in 2025, its largest moves.
• Core Scientific's Capital Expenditures stood at -$62.3 million in 2022, then surged by 118.68% to $11.6 million in 2023, then surged by 146.96% to $28.8 million in 2024, then surged by 871.03% to $279.2 million in 2025, then surged by 39.38% to $389.2 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $389.2 million, $279.2 million, and $244.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison